—

Remedium Capital Partners, LLC

Q4 2025 13F Holdings

  • Location
    fort lauderdale, FL
  • Num holdings

    6

  • Value ($000)

    $170

  • Date Filed
    02/12/2026
  • Form type
    13F-HR
  • CIK
    0002104501
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
S
SYRE

Spyre Therapeutics Inc

COM
00773J202
$47.71K
28 %

1,456,231

---

Oruka Therapeutics Inc

COM
687604108
$47.05K
28 %

1,552,414

A
APGE

Apogee Therapeutics Inc

COM
03770N101
$44.05K
26 %

583,591

---

Jade Biosciences Inc

COM
008064206
$24.35K
14 %

1,577,750

---

Crescent Biopharma Inc

COM
38000Q201
$4.28K
3 %

361,250

---

Galecto Inc

COM
36322Q206
$2.77K
2 %

120,473

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 6 of 6